Table 2.
Sample ID | ID50 in TZM-bl cellsa |
HIV IG (μg/ml) | Tier phenotype | ||||||
---|---|---|---|---|---|---|---|---|---|
S321 | C500 | B520 | G435 | T520b | M263 | M600c | |||
SHIVAD8-CK15 | 63 | 112 | 145 | 36 | 145 | 85 | 64 | >2,500 | 2 |
SHIVAD8-CE8J | 91 | 94 | 112 | 43 | 147 | 137 | 65 | >2,500 | 2 |
SHIVAD8-CL98 | 77 | 54 | 47 | 63 | 198 | 92 | 89 | 1,870 | 2 |
HIVAD8 | 189 | <20 | <20 | <20 | <20 | <20 | 25 | 2,032 | 3 |
MN.3 | 13,944 | 9,152 | 822 | 8,432 | 3,968 | 43,722 | 1,709 | 1.81 | 1 |
CAAN5342.A2 | 84 | <20 | 27 | <20 | <20 | 77 | 185 | 638 | 2 |
ID50, serum dilution at which relative luminescence units were reduced 50% compared to virus control wells (no test sample).